Tab navigation

Presentations

 

Monday, 22 October 2018

18.00

Networking reception and dinner for speakers at the Centre for Global Dialogue

 

Tuesday, 23 October 2018

 

Event moderation: Séverine Rion Logean, Life & Health R&D Manager, Swiss Re

08.00

Welcome coffee

08.30

Welcome and introduction

Justine Kelly-Fisher, Head L&H Business Management Client Service Delivery, Swiss Re

Topic

From science fiction to practice

08.35

Building an evidence base for the future of genomic medicine

Robert Green, Geneticist, Brigham and Women's Hospital; Professor of Medicine, Harvard Medical School

08.55

Genome editing: What will the future bring?

Rodger Novak, Co-Founder and President, CRISPR Therapeutics

09.15

(Nearly) 100,000 genomes later: What have we learned?

Mark Bale, Head of Science Partnerships, Genomics England / Department of Health & Social Care, UK

09.35

Polygenic risk scores for risk assessment

Richard Karlsson Linnér, Postdoctoral Researcher, School of Business and Economics, Vrije Universiteit Amsterdam

09.55

Panel discussion on the current status and future of genomic medicine: From early detection to cure

Moderated by Christoph Nabholz, Head Life & Behaviour R&D, Swiss Re

Mark Bale, Head of Science Partnerships, Genomics England / Department of Health & Social Care, UK
Stefan Foser, Group International Scientific Director, Roche
Thilo Schroeder, Partner, Nextech Invest Ltd.

10.35

Coffee break

11.00

Workshops

Round 1 starts at 11:00
Round 2 starts at 11:30

Workshop session 1: Personalised medicine in the clinical practice and what it means for insurance

Expert: Stefan Foser, Group International Scientific Director, Roche
Moderator: Giselle Abangma, Senior L&H Research Analyst, Swiss Re

Workshop session 2: Is reversal of genetic disease a reality? Risks and opportunities for insurance

Expert: Rodger Novak, Co-Founder and President, CRISPR Therapeutics
Moderator: Thomas Wildhaber, Financial Analyst, Swiss Re

Workshop session 3: The cost and value of the interpretome

Expert: Mark Bale, Head of Science Partnerships, Genomics England / Department of Health & Social Care, UK
Moderator: Yommy Chiu, Life & Health R&D Manager, Swiss Re

Workshop session 4: Polygenic risk scores vs. traditional risk factors in underwriting

Expert: Pietro Biroli, Assistant Professor of Economics, University of Zurich and Richard Karlsson Linnér, Postdoctoral Researcher, School of Business and Economics, Vrije Universiteit Amsterdam
Moderator: John Schoonbee, Global Chief Medical Officer, Swiss Re

12.00

Lunch

Topic

A look at today's practice

13.20

Precision medicine: A reality check

Stefan Foser, Group International Scientific Director, Roche

13.40

The value proposition of genetic testing as an insurance offering

Marko Bitenc, Founder and CEO, GenePlanet

14.00

Genetics and genomics: A view from daily practice in oncology today and tomorrow

Beat Thürlimann, Head of Breast Center, Cantonal Hospital St. Gallen

14.20

Potential for genetic information to promote healthier behaviours

Colleen McBride, Rollins Professor and Chair, Department of Behavioral Sciences & Health Education, Emory University

14.40

Panel discussion on the value proposition in insurance: How to motivate individuals to take action on information gained through genetic testing?

Moderated by Lizzy Lubczanski, Behavioural Research Manager, Swiss Re

Robert Green, Geneticist, Brigham and Women's Hospital; Professor of Medicine, Harvard Medical School
Colleen McBride, Rollins Professor and Chair, Department of Behavioral Sciences & Health Education, Emory University
Beat Thürlimann, Head of Breast Center, Cantonal Hospital St. Gallen

15.20

Coffee break

15.45

Workshops

Round 1 starts at 15:45
Round 2 starts at 16:15

Workshop session 1: The impact of genomic medicine on behaviour and insurance

Expert: Robert Green, Geneticist, Brigham and Women's Hospital; Professor of Medicine, Harvard Medical School
Moderator: Florian Rechfeld, Senior Research Analyst L&H, Swiss Re

Workshop session 2: Exploring the insurance value proposition of genetic testing

Expert: Marko Bitenc, Founder and CEO, GenePlanet
Moderator: Tsutomu Nemoto, Life & Behaviour Research Analyst, Swiss Re

Workshop session 3: Challenges and dilemmas in clinical counselling

Expert: Beat Thürlimann, Head of Breast Center, Cantonal Hospital St. Gallen
Moderator: Monica Wilson, Chief Medical Officer, Swiss Re

Workshop session 4: Potential for genetic information to promote healthier behaviours

Expert: Colleen McBride, Rollins Professor and Chair, Department of Behavioral Sciences & Health Education, Emory University
Moderator: Tiffany Zhang, Behavioural Research Consultant, Swiss Re

16.50

Closing remarks and next steps

Christoph Nabholz, Head Life & Behaviour R&D, Swiss Re

17.00

End of event

This event may be photographed, filmed and/ or recorded. A summary of the event, pictures and/or a video of the event in which you may appear may be posted and made available on Swiss Re’s and the Swiss Re Centre for Global Dialogue’s internal and external websites and in printed materials.